Back to top

messenger-rna: Archive

Zacks Equity Research

FDA Approves Pfizer, Moderna's Omicron COVID Jabs in Younger Kids

Amid a rise in seasonal respiratory illnesses in younger children across the country, the FDA broadens the label of authorized bivalent Omicron BA.4/BA.5-adapted vaccines to include children as young as six months.

PFENegative Net Change MRNANegative Net Change BNTXNegative Net Change

Zacks Equity Research

Pfizer (PFE) Seeks FDA Nod for Bivalent COVID Jab in Infants

Pfizer (PFE) and partner BioNTech seek label expansion to use their Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine in young children under five years.

PFENegative Net Change MRKNegative Net Change MRNANegative Net Change BNTXNegative Net Change

Zacks Equity Research

Novavax (NVAX) Stock Nosedives 88% This Year: Here's Why

Novavax (NVAX) drops to record lows as the delayed product launch of its COVID-19 vaccine made it lose market share. Management slashes revenue guidance by more than half.

PFENegative Net Change MRNANegative Net Change NVAXNegative Net Change BNTXNegative Net Change